Ads
related to: atra stock priceinvesco.com has been visited by 1M+ users in the past month
Search results
Does Atara Biotherapeutics (ATRA) Have the Potential to Rally 204% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for Atara Biotherapeutics (ATRA) points to a 204.1% upside in...
The past five years for Atara Biotherapeutics (NASDAQ:ATRA) investors has not been profitable
Simply Wall St. via Yahoo Finance· 1 year agoAtara Biotherapeutics, Inc. (NASDAQ:ATRA) shareholders should be happy to see the share price up 19%...
Analysts Estimate Atara Biotherapeutics (ATRA) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 2 years agoAtara Biotherapeutics (ATRA) doesn't possess the right combination of the two key ingredients for a...
Atara Biotherapeutics (NASDAQ:ATRA) shareholders are up 17% this past week, but still in the red...
Simply Wall St. via Yahoo Finance· 2 years agoThis week we saw the Atara Biotherapeutics, Inc. (NASDAQ:ATRA) share price climb by 17%. But only...
Time To Worry? Analysts Just Downgraded Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Outlook
Simply Wall St. via Yahoo Finance· 10 months agoThe latest analyst coverage could presage a bad day for Atara Biotherapeutics, Inc. (NASDAQ:ATRA),...
Earnings Beat: Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Just Beat Analyst Forecasts, And Analysts...
Simply Wall St. via Yahoo Finance· 2 years agoAtara Biotherapeutics, Inc. (NASDAQ:ATRA) just released its first-quarter report and things are...
After losing 76% in the past year, Atara Biotherapeutics, Inc. (NASDAQ:ATRA) institutional owners...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Institutions' substantial holdings in Atara Biotherapeutics implies that they have...
Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 1 year agoAtara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -5.13% and 2.13%,...
Atara (ATRA) Up 11% on Regulatory Update From Blood Cancer Study
Zacks via Yahoo Finance· 7 months agoAtara (ATRA) rises 11% on an update regarding the regulatory pathway for the company's lead product...
Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding
GuruFocus.com via Yahoo Finance· 3 months agoOverview of Seth Klarman (Trades, Portfolio)'s Recent Stock Transaction Renowned value investor Seth...
